Renaissance Capital LLC 10x Genomics, Inc. Transaction History

Renaissance Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$36.95 - $82.41 $537,474 - $1.2 Million	14,546 Added 54.84%	41,072 $1.86 Million
Q1 2022 May 12, 2022	SELL	$55.7 - $145.79 $442,369 - $1.16 Million	-7,942 Reduced 23.04%	26,526 $2.02 Million
Q4 2021 Feb 01, 2022	SELL	$135.05 - $182.59 $756,820 - $1.02 Million	-5,604 Reduced 13.98%	34,468 $5.13 Million
Q3 2021 Feb 01, 2022	SELL	$145.58 - $192.14 $8.33 Million - $11 Million	-57,209 Reduced 58.81%	40,072 $5.83 Million
Q2 2021 Feb 01, 2022	BUY	$134.22 - $202.37 $2.38 Million - $3.59 Million	17,763 Added 22.34%	97,281 $19.1 Million
Q1 2021 Feb 01, 2022	SELL	$140.25 - $196.86 $3.9 Million - $5.48 Million	-27,824 Reduced 25.92%	79,518 $14.4 Million
Q4 2020 Feb 01, 2022	BUY	$126.47 - $163.7 $13.6 Million - $17.6 Million	107,342 New	107,342 $15.2 Million

292

96.6M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.42B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Renaissance Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Capital LLC with notifications on news.